Table 1.
Patient # | Sex | Age | Primary Tumor Localization | Identified Mutations | Method | Metastatic Sites |
---|---|---|---|---|---|---|
99 | Male | 61 | Caecum | Kras G13D | ctDNA | Peritoneum |
124 | Male | 40 | Transverse colon | Kras G12V | ctDNA | Peritoneum and liver |
129 | Male | 79 | Right colon | Kras G12V | NGS on primary tumor biopsy | Liver |
130 | Female | 43 | Rectum | no | NGS on primary tumor biopsy | Liver and anal canal |
134 | Female | 62 | Right colic flexure | Braf V600G | NGS on primary tumor biopsy | Liver and Lung |
143 | Male | 73 | Sigmoid colon | no | NGS on primary tumor biopsy | Liver |
144 | Male | 70 | Transverse colon | Kras G12V | ctDNA | Liver and Lung |
149 | Male | 62 | Right colon | Kras G12V | NGS on primary tumor biopsy | Liver |
170 | Female | 48 | Right colon | Kras G12D | PCR and sequencing | Liver and bones |
174 | Female | 59 | Transverse colon | STK11 | NGS | Peritoneum and liver |
178 | Female | 55 | Rectum | Kras G12C | PCR and sequencing | Liver and Lung |
180 | Female | 69 | Rectum | Kras G12V and PTEN | NGS | Lung |
183 | Male | 71 | Right colon | BRAFV600E and IDH1 | NGS | Peritoneum |